The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Pooled prevalence and subgroup variations of Tetralogy of Fallot among children and adolescents with congenital heart defect in Sub-Saharan Africa: A systematic review and meta-analysis
Open accessAbstract
BACKGROUND: Tetralogy of Fallot is one of the critical congenital heart defects needing intervention within the first year of life. OBJECTIVE: This review aims to systematically assess the prevalence of Tetralogy of Fallot among children and adolescents with congenital heart defects in Sub-Saharan Africa from January 2000 to January 2024. METHODS: All original observational studies focused on children and adolescent population diagnosed with congenital heart defects within Sub-Saharan Africa; reported the primary outcome of interest were included. Prisma guidelines were utilized to perform this systematic review and meta-analysis. Electronic databases including Medline (PubMed), Scopus, Google Scholar, and African Index Medicus were searched. A weighted inverse variance random-effects model was employed to estimate the pooled prevalence of Tetralogy of Fallot. RESULTS: Thirty-one studies included encompassing a total of 11,265 participants from 15 Sub-Saharan African countries with representation from Southern (4 studies, 619 participants), Central (5 studies, 2,220 participants), Eastern (11 studies, 3,384 participants), and Western (11 studies, 5,042 participants). Cross-sectional studies comprised (25 studies, 8,909 participants), and cohort design (6 studies, 2,356 participants). The analysis revealed a pooled prevalence of 10% (95% CI: 9%; 12%) with I2 (77%, p-value < 0.01). The subgroup analysis based on geographic regions revealed statistically significant difference. CONCLUSIONS AND FUTURE IMPLICATIONS: The prevalence of Tetralogy of Fallot observed was found considerably higher compared to global estimate and reports of developed countries. In a subgroup analysis based on the geographic region, a surprisingly high prevalence was reported across all regions of Sub-Saharan Africa. The substantial disparities and high prevalence observed underscores the complex interplay of factors influencing occurrence of Tetralogy of Fallot. Identifying the true scope of Tetralogy of Fallot burden may help policymakers and healthcare providers to prioritize interventions, optimize resource allocation, and potentially improve its outcomes in Sub-Saharan Africa.
Overview
CoChat Summary
TL;DR
This systematic review and meta-analysis estimated the pooled prevalence of Tetralogy of Fallot among children and adolescents with congenital heart defects in Sub-Saharan Africa. Across 31 studies and 11,265 participants, the pooled prevalence was 10% (95% CI: 9%; 12%), with significant geographic variation.
Key findings
- Pooled TOF prevalence was 10% (95% CI: 9%; 12%) among 11,265 CHD cases from 31 studies in 15 Sub-Saharan African countries, with high heterogeneity (I² = 77%, p < 0.01).
- Geographic subgroup prevalence differed significantly (p = 0.01): Southern 14% (95% CI: 7%; 21%), Western 12% (95% CI: 10%; 13%), Eastern 9% (95% CI: 7%; 12%), and Central 8% (95% CI: 7%; 9%).
- Among 10 studies reporting sex distribution, pooled TOF proportion was higher in males, 5% (95% CI: 4%; 7%), than females, 3% (95% CI: 2%; 4%).
- Study design, publication year, and income-level subgroups were not statistically significant: cross-sectional 10% vs cohort 12% (p = 0.37); publication year p = 0.98; income level p = 0.08.
Methods
- Systematic review and meta-analysis following PRISMA, searching Medline (PubMed), Scopus, Google Scholar, and African Index Medicus on January 5, 2024, plus manual reference-list searches.
- Included original observational studies of children and adolescents aged 0–18 years with CHD in Sub-Saharan Africa, published in English after 2000, reporting TOF prevalence and total CHD cases.
- Random-effects inverse-variance meta-analysis in R version 4.3.3 using the “meta” package; assessed heterogeneity with I², publication bias with funnel plot and Egger’s test, sensitivity via leave-one-out, and subgroup/meta-regression analyses.
Limitations
- Stated by the paper: exclusion of non-English articles may have missed relevant French-language studies; scarcity of studies directly reporting TOF prevalence meant reliance on CHD studies with indirect TOF reporting, likely contributing to heterogeneity; grey literature was not considered.
- Evident from the text: heterogeneity was high (I² = 77%), and the funnel plot was asymmetric although Egger’s test was non-significant (p = 0.49).
- Evident from the text: sex distribution data were available in only 10 of 31 studies, and no included study was published between 2000 and 2005.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig 1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram. Results of search and reasons for exclusion of studies for TOF prevalence review in Sub-Saharan Africa [53].](https://figures.cochat.ai/paper-figures/ff531b3aef0f46a0a01e0b38a5daa19c/pooled-prevalence-and-subgroup-variations-of-tetralogy-of-fallot-among-children-figure-1.jpg)






Verification
Claims the paper makes
4 Valid · 3 Not valid · 4 Not checked · 38 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“The prevalence of Tetralogy of Fallot observed was found considerably higher compared to global estimate and reports of developed countries.”
- Also stated in: § Discussion · plain
“Despite limitations in healthcare access and diagnostic expertise in Sub-Saharan Africa, the prevalence observed in this region was found considerably higher compared to developed countries.”
§ Pooled prevalence and subgroup variations of Tetralogy of Fallot among children and adolescents with congenital heart defect in Sub-Saharan Africa: A systematic review and meta-analysis > Abstract > Conclusions and future implications
What the sources say
- Partly supportedcites [10] Y Liu, 2019, Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies, International Journal of Epidemiology sourceExperimental — accuracy not yet measured
Table 1 in the Results gives a global Tetralogy of Fallot birth-prevalence estimate of 0.356 per thousand, supporting the use of a global benchmark. The paper does not compare that estimate with the citing study’s observed prevalence or provide a Tetralogy-specific comparison with developed countries. Its regional finding that Africa had the lowest reported prevalence concerns congenital heart defects overall, not Tetralogy of Fallot specifically. (LLM, conf=0.85)
- Could not verifycites [2] ME Oster, 2013, Temporal trends in survival among infants with critical congenital heart defects, Pediatrics sourceExperimental — accuracy not yet measured
Table 2 and the Results report prevalence for congenital heart defects and critical congenital heart defects in metropolitan Atlanta, not Tetralogy of Fallot separately. The Discussion compares overall critical-defect prevalence with European estimates but does not address Sub-Saharan Africa or the claimed Tetralogy of Fallot comparison (searched for Tetralogy-specific prevalence and regional comparisons). (LLM, conf=0.78)
- Not checked — no full text of the sourcecites [13] QM Zhao, 2019, Prevalence of congenital heart disease at live birth in China, The Journal of pediatrics source
- Disputedcites [14] Y Zhang, 2011, Observed prevalence of congenital heart defects from a surveillance study in China, Journal of Ultrasound in Medicine sourceExperimental — accuracy not yet measured
Zhang et al. (2011) report a Tetralogy of Fallot prevalence of only 1.0 per 1000 births (n = 4, 5.3% of 75 cases; Results, Table 3), and its Discussion states the opposite of the claim for this defect class: 'Our observed prevalence rate for major congenital heart defects was similar to those in recent reports' and 'Our prevalence estimates for other congenital heart defect types were similar to those noted previously.' The paper's 'higher than rates reported in other countries' statement (Conclusions; Discussion) applies only to the total prevalence of all congenital heart defects (18.7 per 1000), which the authors attribute to the inclusion of many minor defects (small VSDs, ASDs) detected by universal neonatal echocardiography — not to tetralogy of Fallot. So nothing in our copy supports a considerably higher observed ToF prevalence relative to global or developed-country estimates. (LLM, conf=0.72)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [17] E Leirgul, 2014, Birth prevalence of congenital heart defects in Norway 1994–2009—A nationwide study, American Heart Journal/the American Heart Journal sourceExperimental — accuracy not yet measured
Our copy of the Norwegian study does supply a developed-country ToF figure that the citing authors can compare against: the Results and Table I report ToF at 2.7 per 10,000 births (2.6 per 10,000 live births, 243 cases among 954,413 births). However, the paper makes no comparison of ToF with a global estimate and says nothing about Sub-Saharan Africa; its international comparisons (Discussion) concern the composite severe-CHD prevalence (30.7 per 10,000 vs EUROCAT 17.7, Atlanta 24.9, Quebec 15.7), and its only worldwide figure is the general CHD range of 5-10 per 1,000 live births quoted from van der Linde et al. 2011. So the 'considerably higher than global estimate' part of the attributed claim, and the comparison itself, are the citing authors' conclusion and are not stated in this source. (LLM, conf=0.68)
- Not checked — no full text of the sourcecites [47] A Bassili, 2000, Congenital heart disease among school children in Alexandria, Egypt: an overview on prevalence and relative frequencies, Journal of tropical pediatrics source
- Partly supportedcites [48] AM Mansour, 2018, Prevalence and pattern of congenital heart disease in South Libya, Journal of Medical Sciences sourceExperimental — accuracy not yet measured
Our copy of Mansour (2018) supplies only the observation: in the Results/Abstract passage, 11 of 425 CHD cases (2.6%) had tetralogy of Fallot, behind PDA (26.8%), ASD (14.8%), PR (14.8%) and VSD (13.2%), and the paper concludes that TGA — not TOF — was the most common cyanotic lesion. Nothing in our copy compares this TOF figure with a 'global estimate' or with 'reports of developed countries'; two targeted searches (TOF prevalence vs global estimate/developed countries; discussion/comparison with other studies) returned no such statement, so the comparative conclusion attributed to this source is unsupported. The source is also a single hospital series in South Libya (Sebha Medical Center, 2015-2016), i.e. North Africa, not the Sub-Saharan-Africa prevalence the citing paraphrase generalises to. (LLM, conf=0.70)
- Disputedcites [49] MT Ali, 2016, Prevalence of congenital heart disease among children in Aljabal Alkhdhar region, Libya: An Echocardiographic study, Al-Mukhtar Journal of Sciences sourceExperimental — accuracy not yet measured
Our copy reports Tetralogy of Fallot in 12 patients (3.5% of 342 CHD cases, the most frequent cyanotic anomaly; Abstract and Results, Table 1), but it never describes that figure as higher than global or developed-country estimates. On the contrary, the Abstract states 'The Prevalence rate of CHD in this region compare to the international standard is almost similar', and the Discussion states that 'Distribution of cardiac defects in our children was not very different from the reported series', citing series from both a developed country (Mark et al., 2008, metropolitan Atlanta) and tropical Africa (Sani et al., 2007, Nigeria). The paper's population is also Aljabal Alakhdar, eastern Libya (North Africa), not Sub-Saharan Africa, so the comparative claim attributed to it is contradicted rather than supported. (LLM, conf=0.72)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Discussion · plain
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Similar trends are observed in Central Sub-Saharan Africa (Cameroon, Republic of the Congo) with a range of 6% to 13% [29–33].”
§ Pooled prevalence and subgroup variations of Tetralogy of Fallot among children and adolescents with congenital heart defect in Sub-Saharan Africa: A systematic review and meta-analysis > Introduction
What the sources say
- Not checked — no full text of the sourcecites [29] F Kamdem, 2018, Clinical, echocardiographic, and therapeutic aspects of congenital heart diseases of children at D ouala General Hospital: A cross-sectional study in sub-S aharan A frica, Congenital Heart Disease source
- Not checked — no full text of the sourcecites [30] YF Puepi, 2022, Profile and Outcome of Congenital Heart Disease in Buea, South West Region of Cameroon: A Cross-Sectional Study, J Pediatric Adv Res source
- Disputedcites [31] C Nkoké, 2017, Trends in pediatric echocardiography and the yield for congenital heart disease in a major cardiac referral hospital in Cameroon, Translational Pediatrics sourceExperimental — accuracy not yet measured
The Results report tetralogy of Fallot in 12 children, or 5.3% of those with diagnosed structural congenital heart disease, at the Cameroon hospital. That figure falls below the cited 6%–13% range. This paper does not provide a figure for the Republic of the Congo. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
- Supportedcites [32] D Chelo, 2016, Spectrum of heart diseases in children: an echocardiographic study of 1,666 subjects in a pediatric hospital, Yaounde, Cameroon, PubMed doi:10.3978/j.issn.2223-3652.2015.11.04
The Discussion reports that Tetralogy of Fallot accounted for 8.2% of congenital heart diseases in the study’s Cameroon series, within the stated 6%–13% range. As one source in a citation cluster, this paper supports the Cameroon component of the claim. (LLM, conf=0.91)
- Supportedcites [33] AB Loufoua-Lemay, 2016, Epidemiology of cardiovascular diseases in children at the teaching hospital of Brazzaville, Congo, World Journal of Cardiovascular Diseases source
Section 3.5 reports Tetralogy of Fallot in 32 patients, or 10.1% of cases, at the Brazzaville hospital in the Republic of the Congo. That figure falls within the cited 6%–13% range; this source supports the Congolese component of the multi-citation statement, not the Cameroon figures. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Studies from West Africa (Nigeria, Niger, and Senegal) reported TOF prevalence ranging from 7% to 15% among all CHD cases [4, 19–28].”
§ Pooled prevalence and subgroup variations of Tetralogy of Fallot among children and adolescents with congenital heart defect in Sub-Saharan Africa: A systematic review and meta-analysis > Introduction
What the sources say
- Partly supportedcites [4] BA Animasahun, 2016, The burden of Fallot’s tetralogy among Nigerian children, Cardiovascular Diagnosis and Therapy sourceExperimental — accuracy not yet measured
The Results report that TOF accounted for 14.7% of congenital heart disease cases at a Nigerian hospital, supporting the Nigerian figure within the claimed range. The Discussion reports other Nigerian rates, but our copy gives no 7% figure or country-specific findings for Niger or Senegal. Because the sentence cites several sources, those other figures may come from elsewhere, but this paper alone does not establish the stated West African range. (LLM, conf=0.88)
- Supportedcites [19] AMZ Zakaria, 2021, Congenital heart disease: Epidemiological and echocardiographic aspects of 167 cases at the Teaching Hospital of Lamorde / Niamey / Niger, Cardiology & Vascular Research (Wilmington, Del) source
Table 4 reports 16 tetralogy of Fallot cases among 167 congenital heart disease cases in Niger, or 9.58%, within the cited 7%–15% range. This source supplies the Niger finding in a sentence citing multiple studies; it does not need to supply the Nigeria and Senegal findings. (LLM, conf=0.92)
- Partly supportedcites [20] JM Chinawa, 2013, Synopsis of congenital cardiac disease among children attending University of Nigeria Teaching Hospital Ituku Ozalla, Enugu, BMC Research Notes sourceExperimental — accuracy not yet measured
Table 2 (Results > Demography) reports TOF in 9 of 71 children (12.7%) at a Nigerian hospital, within the claimed 7–15% range. But the 71 were children with cardiac disease, including acquired rheumatic heart disease, rather than exclusively congenital heart defect cases; this paper also provides no figures for Niger or Senegal. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [21] WE Sadoh, 2013, Congenital heart disease in Nigerian children: a multicenter echocardiographic study, World Journal for Pediatric and Congenital Heart Surgery source
- Not checked — no full text of the sourcecites [22] EN Ekure, 2009, Congenital heart diseases associated with identified syndromes and other extra-cardiac congenital malformations in children in Lagos, West African Journal of Medicine source
- Not checked — no full text of the sourcecites [23] EN Ekure, 2018, Clinical epidemiology of congenital heart disease in Nigerian children, 2012–2017, Birth defects research source
- Not checked — no full text of the sourcecites [24] Nigerian Pediatric Cardiology Study Group, 2017, Congenital heart defects in Nigerian children: preliminary data from the National Pediatric Cardiac Registry, World Journal for Pediatric and Congenital Heart Surgery source
- Not checked — no full text of the sourcecites [25] BE Adebayo, 2016, The spectrum of structural heart defects seen in children at the University College Hospital, Ibadan, Nigerian Journal of Cardiology source
- Supportedcites [26] AT Chinawa, 2021, Compendium of cardiac diseases among children presenting in tertiary institutions in southern Nigeria: a rising trend, Libyan Journal of Medicine source
In Results, Table 2 (page unavailable), the study reports 51 TOF cases among 439 children with cardiac disease; 83.6% had congenital defects. That makes TOF approximately 13.9% of congenital-defect cases, within the claimed 7%–15% range. This Nigerian study supports the Nigeria component of the multi-cited sentence, not figures for Niger or Senegal. (LLM, conf=0.88)
- Supportedcites [27] BE Otaigbe, 2014, Congenital heart disease in the Niger Delta region of Nigeria: a four-year prospective echocardiographic analysis: cardiovascular topic, Cardiovascular journal of Africa source
The Results (Table 3) report that tetralogy of Fallot accounted for 28 of 332 CHD cases (8.4%) in this Nigerian study, within the stated 7%–15% range. This source supports the Nigeria portion of the multi-cited statement; the other countries are not attributed to this source alone. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The subgroup analysis examining income level also did not identify a statistically significant difference in TOF prevalence between income categories (p-value = 0.08).”
§ Pooled prevalence and subgroup variations of Tetralogy of Fallot among children and adolescents with congenital heart defect in Sub-Saharan Africa: A systematic review and meta-analysis > Results > Subgroup analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The highest prevalence was observed in the Southern region, with an estimated 14% (95% CI: 7%; 21%).”
§ Pooled prevalence and subgroup variations of Tetralogy of Fallot among children and adolescents with congenital heart defect in Sub-Saharan Africa: A systematic review and meta-analysis > Results > Subgroup analysis
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
22 more claims
Create a free account to see all 49 claims and to verify the 7 references still open.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 11
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Pooled prevalence and subgroup variations of Tetralogy of Fallot among children and adolescents with congenital heart defect in Sub-Saharan Africa: A systematic review and meta-analysis > Discussion
“Studies published in earlier times, 2006–2011 and 2012–2017 reported a slightly lower prevalence at 10% (95% CI: 9%; 12%) and 10% (95% CI: 4%; 17%), respectively.”
§ Pooled prevalence and subgroup variations of Tetralogy of Fallot among children and adolescents with congenital heart defect in Sub-Saharan Africa: A systematic review and meta-analysis > Results > Subgroup analysis
“This was followed by studies published between 2012 and 2017, 10% (95% CI: 9%; 12%), and 2006 to 2011, 10% (95% CI: 4%; 17%) (Fig 5).”
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Birth prevalence of congenital heart disease worldwide
van der Linde, D., Konings, E. E. M., Slager, M. A., Witsenburg, M., Helbing, W. A., Takkenberg, J. J. M., & Roos-Hesselink, J. W. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.025 · Cited by 3,452
Liu, Y., Chen, S., Zühlke, L., Black, G. C., Choy, M.-K., Li, N., & Keavney, B. D. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz009 · Cited by 1,436
Patsopoulos, N. A., Evangelou, E., & Ioannidis, J. P. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dyn065 · Cited by 1,138
Temporal trends in survival among infants with critical congenital heart defects
Oster, M. E., Lee, K. A., Honein, M. A., Riehle-Colarusso, T., Shin, M., & Correa, A. (2013) · Pediatrics · doi:10.1542/peds.2012-3435 · Cited by 716
Progressive familial intrahepatic cholestasis
Davit-Spraul, A., Gonzales, E., Baussan, C., & Jacquemin, E. (2009) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-4-1 · Cited by 482
Bailliard, F., & Anderson, R. H. (2009) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-4-2 · Cited by 345
Prevalence of Congenital Heart Disease at Live Birth in China
Zhao, Q.-M., Liu, F., Wu, L., Ma, X.-J., Niu, C., & Huang, G.-Y. (2019) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.08.040 · Cited by 222
Birth prevalence of congenital heart defects in Norway 1994-2009—A nationwide study
Leirgul, E., Fomina, T., Brodwall, K., Greve, G., Holmstrøm, H., Vollset, S. E., Tell, G. S., & Øyen, N. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.07.030 · Cited by 164
Trends in congenital anomalies in Europe from 1980 to 2012
Morris, J. K., Springett, A. L., Greenlees, R., Loane, M., Addor, M.-C., Arriola, L., Barisic, I., Bergman, J. E. H., Csaky-Szunyogh, M., Dias, C., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0194986 · Cited by 159
Research works printed but not linked: 2
- J Diaz-Frias, 2024, StatPearls
- F Talarge, 2018, Congenital heart defects and associated factors in children with congenital anomalies, Ethiopian medical journal, 56, 335
Cited by
Joram, N. L. (2026) · Cardiology in the Young · doi:10.1017/s1047951126112906 · Cited by 1
Bamigboye-Taiwo, O. T., Okeniyi, J., Adeyefa, B. S., Afolabi, S. A., Otetubi, O. A., & Obrerhor, O. E. (2026) · Cardiology in the Young · doi:10.1017/s1047951126113456
Li, Y., Yao, Z., Chen, L., Zhong, J., Zheng, M., Wang, X.-M., Chen, Y., Sun, X., Liu, Y., & He, S. (2025) · BMC Pediatrics · doi:10.1186/s12887-025-05892-2 · Cited by 1
Metadata
- Authors
- Geleta, B. E., & Mulu, A.
- Affiliations
- Addis Ababa University (ET)
- Corresponding author
- Geleta, Biniam Endale
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2025-01-17
- Volume
- 20
- Issue
- 1
- Pages
- e0311686
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC11741593
- OpenAlex
- W4406527991
- Semantic Scholar
- 1bde0dbe67050669807e272aa4138ba4cf527fc8
- Cited by
- 5
- References
- 53
- Citations by year
- 2026: 4 · 2025: 1
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Congenital Heart Disease Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cardiovascular and Diving-Related Complications
- Keywords
- tetralogy of Fallot, congenital heart disease, prevalence, sub-Saharan Africa, children and adolescents, regional variation
- MeSH terms
- Adolescent, Child, Female, Heart Defects, Congenital, Humans, Male, Tetralogy of Fallot, Prevalence, Africa South of the Sahara
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pooled prevalence and subgroup variations of Tetralogy of Fallot among children and adolescents with congenital heart defect in Sub-Saharan Africa: A systematic review and meta-analysis. https://app.cochat.ai/papers/10.1371/journal.pone.0311686
- The paper
- Geleta, B. E., & Mulu, A. (2025). Pooled prevalence and subgroup variations of Tetralogy of Fallot among children and adolescents with congenital heart defect in Sub-Saharan Africa: A systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0311686
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.